Birmingham, West Midlands -- (SBWIRE) -- 12/18/2013 -- Value Penny Stocks issues special report on Marvell Technology Group Ltd. (NASDAQ:MRVL), JetBlue Airways Corporation (NASDAQ:JBLU), Biodel Inc (NASDAQ:BIOD), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX).
Marvell Technology Group Ltd. (NASDAQ:MRVL) opened its last trade at the price of $13.69. Its closing price was $13.56 after losing -0.40% for the day. The company traded with the total volume of 7 6,812,820 shares, while its average trading volume remained 7.69 million shares. The beta of this stock stands at 0.92. Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone ARM-based microprocessor integrated circuits. It offers mobile and wireless products comprising communications and applications processors.
Has MRVL Found The Bottom and Ready To Move Up? Find Out Here
JetBlue Airways Corporation (NASDAQ:JBLU) percentage change plunged -3.47% to close at $8.49 with the total traded volume of 6,571,860 shares, along with average volume of 7.26 million shares. The 52 week range of the stock remained $5.55 - $9.20, while its day lowest price was $8.40. The share price hit the day highest price of $8.76. JetBlue Airways Corporation, a passenger airline company, provides air transportation services. The company also provides in-flight entertainment for commercial aircraft, including live in-seat satellite television, digital satellite radio, wireless aircraft data link service, and cabin surveillance systems.
Has JBLU Found The Bottom And Ready To Gain Momentum? Find Out Here
Biodel Inc (NASDAQ:BIOD) traded on volume of 6,141,602 shares in the last session against average volume of 312,896.00 shares. The company started its trading session with the price of $2.45 and closed at $2.31 by scoring +5.00%. Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. The company is involved in developing proprietary formulations of injectable recombinant human insulin for the treatment of patients with type 1 and type 2 diabetes.
Will BIOD Continue To Move Higher? Find Out Here
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) started its last trading session with the price of $1.70 and closed at $1.80 by scoring 4.05%. The stock traded with total volume of 5,590,244 million shares, while the average trading volume remained 930,015.00 shares. The beta value of this stock stands at 2.11. Day range for the stock was $1.70 - $1.82. Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for human disease. Its portfolio of orally-delivered small molecule compounds in clinical development include LX4211 that has completed two Phase II clinical trials for the treatment of type 1 and type 2 diabetes.
Why Should Investors Buy LXRX After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)